GERN vs. RMD

In the year-to-date period, GERN achieves a 1.69% return, which is significantly higher than RMD's -0.09% return. Over the past 10 years, GERN has underperformed RMD with an annualized return of 1.03%, while RMD has yielded a comparatively higher 16.41% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GERN Sharpe Ratio is 0.62, which is lower than the RMD Sharpe Ratio of 0.91. The chart below compares the historical Sharpe Ratios of GERN and RMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GERN has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 0.88%.

The maximum GERN drawdown since its inception was -98.65%, which is greater than RMD's maximum drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for GERN and RMD. For additional features, visit the drawdowns tool.

Geron Corporation (GERN) has a higher volatility of 10.89% compared to ResMed Inc. (RMD) at 7.83%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Geron Corporation and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.